V. Gupta

发表

In Silico Screening, Genotyping, Molecular Dynamics Simulation and Activity Studies of SNPs in Pyruvate Kinase M2

N. Subbarao, R. Bamezai, B. Kumar, 2015, PloS one.

Dosage Compensation in the Mouse Balances Up-Regulation and Silencing of X-Linked Genes

Jeannie T. Lee, B. Turner, F. Falciani, 2007, PLoS biology.

RNF4-Dependent Hybrid SUMO-Ubiquitin Chains Are Signals for RAP80 and Thereby Mediate the Recruitment of BRCA1 to Sites of DNA Damage

Christopher E. Berndsen, R. Greenberg, C. Wolberger, 2012, Science Signaling.

Implementation and relevance of FAIR data principles in biopharmaceutical R&D.

Ian Smith, Andrea Splendiani, Jan Taubert, 2019, Drug discovery today.

Human pyruvate kinase M2: A multifunctional protein

R. Bamezai, Vibhor Gupta, V. Gupta, 2010, Protein science : a publication of the Protein Society.

Insulin enhances metabolic capacities of cancer cells by dual regulation of glycolytic enzyme pyruvate kinase M2

R. Bamezai, B. Kumar, Vibhor Gupta, 2013, Molecular Cancer.

A BRISC-SHMT complex deubiquitinates IFNAR1 and regulates interferon responses.

R. Greenberg, S. Fuchs, Kanstantsin V. Katlinski, 2013, Cell reports.

Pyruvate Kinase M2: A Metabolic Tuner

R. Bamezai, B. Kumar, Vibhor Gupta, 2015 .

Differential Behavior of Missense Mutations in the Intersubunit Contact Domain of the Human Pyruvate Kinase M2 Isozyme*

R. Bhat, K. Akhtar, R. Bamezai, 2009, Journal of Biological Chemistry.

Missense Mutations in Pyruvate Kinase M2 Promote Cancer Metabolism, Oxidative Endurance, Anchorage Independence, and Tumor Growth in a Dominant Negative Manner

R. Bamezai, B. Kumar, Vibhor Gupta, 2014, The Journal of Biological Chemistry.

Pyruvate kinase M2 and cancer: an updated assessment

R. Bamezai, R. Bamezai, S. Mazurek, 2014, FEBS letters.

Dominant Negative Mutations Affect Oligomerization of Human Pyruvate Kinase M2 Isozyme and Promote Cellular Growth and Polyploidy*

Nishant Singh, R. Bamezai, M. Faheem, 2010, The Journal of Biological Chemistry.

Pyruvate kinase M2: regulatory circuits and potential for therapeutic intervention.

K. Wellen, R. Bamezai, S. Mazurek, 2014, Current pharmaceutical design.

A Novel BRISC-SHMT Complex Deubiquitinates IFNAR1 and Regulates Interferon Responses

R. Greenberg, S. Fuchs, Kanstantsin V. Katlinski, 2013 .

Development of Gene Therapy Vectors: Remaining Challenges.

I. Hidalgo, Vibhor Gupta, S. Lourenço, 2020, Journal of pharmaceutical sciences.

Genes Are Often Sheltered from the Global Histone Hyperacetylation Induced by HDAC Inhibitors

B. Turner, L. O'Neill, K. Nightingale, 2012, PloS one.